Propynyl (drug)
 | This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Propynyl" drug – news · newspapers · books · scholar · JSTOR (July 2019) |
.svg.png) | |
| Names | |
|---|---|
| Preferred IUPAC name
2-{3,5-Dimethoxy-4-[(prop-2-yn-1-yl)oxy]phenyl}ethan-1-amine | |
| Other names
Propynylmescaline
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider |
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C13H17NO3 | |
| Molar mass | 235.283 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Propynyl (4-propynyloxy-3,5-dimethoxyphenethylamine) is a lesser-known drug of the scaline family. It is closely related in structure to mescaline. Propynyl was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 80 mg, and the duration listed as 8–12 hours.[1] Propynyl produces a body load and few to no mental effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of propynyl.
See also
References
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.